Hit enter to search or ESC to close
Bionaut Labs
  • Vision
  • Science
  • Team
  • News
  • Careers
  • Investors
  • Contact
Category

News

Apr 25 2022
Love0

Bionaut Labs Profiled On “Hope and Help Happen Here” Podcast

By fefifolios News

In this episode of the podcast “Hope and Help Happen Here: A Pediatric Cancer Podcast,” Bionaut CEO Michael Shpigelmacher talks about the promise Bionauts offer in the treatment of one of the most difficult forms of pediatric cancer—Diffuse Intrinsic Pontine Gliomas.

Read More
Apr 19 2022
Love0

Agence France-Presse Profiles Bionaut’s Miniature, Remote-Controlled, Disease-Fighting Robots

By fefifolios News

Agence France-Presse, the world’s largest news agency, recently profiled Bionaut’s work. The article has been published globally and has received more than 130 million views.

Read More
Dec 15 2021
Love0

Bionaut Labs and Candel Therapeutics Announce Strategic Collaboration in Precision-Targeted Delivery of Oncolytic Viral Immunotherapies

By fefifolios News

Companies will work on preclinical development of remote-controlled microscale robots to deliver novel oncolytic viral immunotherapies in specific brain tumors LOS ANGELES and NEEDHAM, Mass., December 15, 2021 (GLOBE NEWSWIRE)…

Read More
Sep 23 2021
Love0

FDA Grants Humanitarian Use Device Designation to Bionaut Labs for Treatment of Dandy Walker Syndrome

By fefifolios News

First-in-class Bionaut™ treatment modality will use remote-controlled microscale robots to treat rare pediatric neurological disorder Company also appoints renowned expert in targeted therapeutics and former Kite CEO Aya Jakobovits, Ph.D.,…

Read More
Jun 24 2021
Love0

FDA Grants Bionaut Labs Orphan Drug Designation to BNL-101 for the Treatment of Malignant Gliomas in Pediatric and Adult Patients

By fefifolios News

The U.S. Food and Drug Administration (FDA) has granted Bionaut Labs orphan drug designation for BNL-101 for the local treatment of all malignant gliomas including diffuse intrinsic pontine glioma in…

Read More
Apr 28 2021
Love0

Good Day LA Says Bionauts Could Become One of the Biggest Breakthroughs in Medicine

By fefifolios News
In this segment from FOX 11’s Good Day LA, reporter Bob DeCastro visits Bionaut Labs and speaks with chief executive Michael Shpigelmacher about the potential life-saving applications of the technology...
Read More
Apr 05 2021
Love0

SCIENCE FACT: Bionaut Labs targets disease with remote-controlled micro-robots

By fefifolios News

L.A. Biz recently sat down with CEO Michael Shpigelmacher to discuss the official launch of the company and the technology behind Bionauts. Bionaut Labs has captured the imagination of the…

Read More
Mar 25 2021
Love0

LA MedTech Week: CEO Michael Shpigelmacher Discusses Bionaut’s Approach to Targeting CNS Disorders

By fefifolios News

In this video, Bionaut Labs CEO Michael Shpigelmacher joins Krisztina ‘Z’ Holly from Good Growth Capital for a fireside chat as part of LA MedTech Week. Shpigelmacher discusses the development…

Read More
Mar 03 2021
Love0

Bionaut Labs Debuts From Stealth Mode to Accelerate Development of New Precision Treatment Modality for Brain Disorders

By fefifolios News

First-in-class Bionaut™ treatment modality uses remote-controlled microscale robots to deliver biologics, nucleic acids, or small molecule therapies locally to targeted brain disease areas $20M financing led by Khosla Ventures supports…

Read More

Bionaut Labs

[email protected]

3767 Overland Ave., Suite 114,
Los Angeles, CA 90034, USA

© 2022 Bionaut Labs.

  • Vision
  • Science
  • Team
  • News
  • Careers
  • Investors
  • Contact